143 related articles for article (PubMed ID: 36344907)
1. Lack of Association Between oral Squamous cell Carcinoma and Li-Fraumeni Syndrome.
Dos Santos ES; Santos-Silva AR
Head Neck Pathol; 2023 Mar; 17(1):277-278. PubMed ID: 36344907
[No Abstract] [Full Text] [Related]
2. Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome.
Guerrini-Rousseau L; Tauziède-Espariat A; Castel D; Rouleau E; Sievers P; Saffroy R; Beccaria K; Blauwblomme T; Hasty L; Bourdeaut F; Grill J; Varlet P; Debily MA
Acta Neuropathol Commun; 2023 Jan; 11(1):3. PubMed ID: 36609284
[No Abstract] [Full Text] [Related]
3. Myelodysplastic/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni Syndrome.
Turner SA; Shaver AC; Kovach AE; Oluwole OO; Mason EF
Leuk Lymphoma; 2019 Dec; 60(13):3312-3315. PubMed ID: 31230491
[No Abstract] [Full Text] [Related]
4. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome.
Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH
Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and imaging surveillance in Li-Fraumeni syndrome.
Raskind WH; Hisama FM; Bennett RL
Lancet Oncol; 2016 Nov; 17(11):e472. PubMed ID: 27819239
[No Abstract] [Full Text] [Related]
6. Identification of a novel TP53 germline mutation in a large Italian Li-Fraumeni syndrome Family.
Capra V; Consales A; Nozza P; Monti P; Inga A; Fronza G
Pediatr Blood Cancer; 2009 Feb; 52(2):303-4. PubMed ID: 18937320
[No Abstract] [Full Text] [Related]
7. Li-Fraumeni syndrome--a molecular and clinical review.
Varley JM; Evans DG; Birch JM
Br J Cancer; 1997; 76(1):1-14. PubMed ID: 9218725
[No Abstract] [Full Text] [Related]
8. Biochemical and imaging surveillance in Li-Fraumeni syndrome - Authors' reply.
Villani A; Malkin D
Lancet Oncol; 2016 Nov; 17(11):e473. PubMed ID: 27819240
[No Abstract] [Full Text] [Related]
9. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
10. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10.
Stone JG; Eeles RA; Sodha N; Murday V; Sheriden E; Houlston RS
Cancer Lett; 1999 Dec; 147(1-2):181-5. PubMed ID: 10660104
[TBL] [Abstract][Full Text] [Related]
12. Brain tumors in Li-Fraumeni syndrome: a commentary and a case of a gliosarcoma patient.
Guidi M; Giunti L; Lucchesi M; Scoccianti S; Giglio S; Favre C; Oliveri G; Sardi I
Future Oncol; 2017 Jan; 13(1):9-12. PubMed ID: 27523101
[No Abstract] [Full Text] [Related]
13. Three Primary Tumors Including EGFR-mutated Non-Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni Syndrome.
Gower A; Kim J; Spector K; Menashe D; Vail E; Natale R
Clin Lung Cancer; 2021 Jan; 22(1):e116-e121. PubMed ID: 33172777
[No Abstract] [Full Text] [Related]
14. What Should a Gynecologist Know about Li-Fraumeni Syndrome? Lessons from a Patient Undergoing Hysterectomy for Benign Indications.
Advolodkina P; Lachiewicz MP; Oprea-Ilies G; Majmudar B; Gordon AN
Gynecol Obstet Invest; 2018; 83(4):410-414. PubMed ID: 29945152
[TBL] [Abstract][Full Text] [Related]
15. Li-Fraumeni versus Pseudo-Li-Fraumeni Syndrome: Key Insights for Interpreting Next-Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes.
Sorscher S; Desnoyers R; Ouyang K; Ramkissoon S
Oncologist; 2017 Sep; 22(9):1084-1085. PubMed ID: 28592622
[TBL] [Abstract][Full Text] [Related]
16. Is Li-Fraumeni syndrome really much more common?
Thomas DM
Hum Mutat; 2017 Dec; 38(12):1619. PubMed ID: 29091331
[No Abstract] [Full Text] [Related]
17. Germline TP53 mutations and Li-Fraumeni syndrome.
Varley JM
Hum Mutat; 2003 Mar; 21(3):313-20. PubMed ID: 12619118
[TBL] [Abstract][Full Text] [Related]
18. Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome.
Katona BW; Powers J; McKenna DB; Long JM; Le AN; Hausler R; Zelley K; Jennings S; Domchek SM; Nathanson KL; MacFarland SP; Maxwell KN
Am J Gastroenterol; 2020 Dec; 115(12):2095-2097. PubMed ID: 32969947
[TBL] [Abstract][Full Text] [Related]
19. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
[TBL] [Abstract][Full Text] [Related]
20. High frequency of de novo mutations in Li-Fraumeni syndrome.
Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
